Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.
Zhang YW, Nasto RE, Varghese R, Jablonski SA, Serebriiskii IG, Surana R, Calvert VS, Bebu I, Murray J, Jin L, Johnson M, Riggins R, Ressom H, Petricoin E, Clarke R, Golemis EA, Weiner LM. Zhang YW, et al. Oncogene. 2016 Mar 31;35(13):1643-56. doi: 10.1038/onc.2015.226. Epub 2015 Jul 13. Oncogene. 2016. PMID: 26165839 Free PMC article.
Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
Schrecengost RS, Riggins RB, Thomas KS, Guerrero MS, Bouton AH. Schrecengost RS, et al. Cancer Res. 2007 Jul 1;67(13):6174-82. doi: 10.1158/0008-5472.CAN-06-3455. Cancer Res. 2007. PMID: 17616674 Free PMC article.
Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, Schuh NR, Donelan SS, Owen KA, Gibson MA, Shupnik MA, Silva CM, Parsons SJ, Clarke R, Bouton AH. Riggins RB, et al. Cancer Res. 2006 Jul 15;66(14):7007-15. doi: 10.1158/0008-5472.CAN-05-3952. Cancer Res. 2006. PMID: 16849545
Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.
Riggins RB, Quilliam LA, Bouton AH. Riggins RB, et al. J Biol Chem. 2003 Jul 25;278(30):28264-73. doi: 10.1074/jbc.M303535200. Epub 2003 May 11. J Biol Chem. 2003. PMID: 12740391
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
Du T, Sikora MJ, Levine KM, Tasdemir N, Riggins RB, Wendell SG, Van Houten B, Oesterreich S. Du T, et al. Among authors: riggins rb. Breast Cancer Res. 2018 Sep 4;20(1):106. doi: 10.1186/s13058-018-1041-8. Breast Cancer Res. 2018. PMID: 30180878 Free PMC article.
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.
Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, Farzanegan A, Roy R, Üren A, Mueller SC, Riggins RB. Heckler MM, et al. Oncotarget. 2016 Jul 26;7(30):47201-47220. doi: 10.18632/oncotarget.9719. Oncotarget. 2016. PMID: 27363015 Free PMC article.
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.
Madhavan S, Gusev Y, Singh S, Riggins RB. Madhavan S, et al. J Exp Clin Cancer Res. 2015 May 15;34(1):45. doi: 10.1186/s13046-015-0150-9. J Exp Clin Cancer Res. 2015. PMID: 25971350 Free PMC article.
50 results
Jump to page
Feedback